Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Dec 11;17:3617–3625. doi: 10.2147/NDT.S337774

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Gao and Wang.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

LncRNA FTX sponges miR-342-3p. (A) The microRNAs lists and scores on predicted by using LncBase Predicted v.2. (B) Predicted miR-342-3p binding sites in lncRNA FTX and dual luciferase report assay in WT- lncRNA FTX or MUT- lncRNA FTX co-transfected with miR-NC or miR-342-3p mimics. (C) Level of miR342-3p in BMECs transfected with shR- lncRNA FTX or oe lncRNA FTX. (D) miR342-3p expression in blood from stroke patients. (E) Proliferation of BMECs was detected by CCK-8 assay. (F) Migration ability was measured by transwell assays. (G) Tube formation assay was used to distinguish angiogenesis ability in BMECs. All values were represented by the mean ± standard deviation. *p<0.05, **p<0.01, ***p <0.001.